INDOCO REMEDIES LTD. - 532612 - Certificate Under Clause 40 Of SEBI (LODR) Reg 2015 For Half Year Ended 30.09.2020
Reg 40(10) - PCS CERTIFICATE FOR HALF YEAR ENDED 30.09.202016-10-2020
16-10-2020
INDOCO REMEDIES LTD. - 532612 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Reg 74(5) of SEBI(DP) Reg 201810-10-2020
INDOCO REMEDIES LTD. - 532612 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- JAYSHANKAR MENONDesignation :- Company Secretary and Compliance Officer10-10-2020
INDOCO REMEDIES LTD. - 532612 - Shareholding for the Period Ended September 30, 2020
Indoco Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here07-10-2020
INDOCO REMEDIES LTD. - 532612 - Compliance Certificate For The Period Ended 30.09.2020- Reg 7(3)
Regulation 7 (3) - Compliance Certificate05-10-2020
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Mr. Abhijit Yashwant Gore as an Additional Independent Director of the Company02-10-2020
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Retirement
Retirement of Independent Director - Mr. Sharad P. Upasani30-09-2020
Indoco Remedies climbs 5 per cent Favipiravir tablets launch for Covid
Shares of Indoco Remedies climbed nearly 5 per cent reacting positively to the reports that the pharma company has launched Favipiravir tablets used i28-09-2020
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Indoco launches FEVINDO 400 (Favipiravir 400mg Tablets)26-09-2020